BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,726 | -28.5% | 6,670 | -13.6% | 0.04% | +2.6% |
| Q2 2023 | $351,860 | +12.3% | 7,723 | 0.0% | 0.04% | -7.1% |
| Q1 2023 | $313,245 | -20.4% | 7,723 | 0.0% | 0.04% | -22.2% |
| Q4 2022 | $393,641 | -6.5% | 7,723 | -1.3% | 0.05% | -19.4% |
| Q3 2022 | $421,000 | -16.1% | 7,823 | 0.0% | 0.07% | -5.6% |
| Q2 2022 | $502,000 | -17.3% | 7,823 | 0.0% | 0.07% | -5.3% |
| Q1 2022 | $607,000 | -14.0% | 7,823 | -4.9% | 0.08% | -21.9% |
| Q4 2021 | $706,000 | +6.6% | 8,227 | 0.0% | 0.10% | +2.1% |
| Q3 2021 | $662,000 | 0.0% | 8,227 | 0.0% | 0.09% | +2.2% |
| Q2 2021 | $662,000 | -4.6% | 8,227 | 0.0% | 0.09% | -15.6% |
| Q1 2021 | $694,000 | +4.7% | 8,227 | -0.5% | 0.11% | -5.2% |
| Q4 2020 | $663,000 | -0.3% | 8,267 | 0.0% | 0.12% | -15.4% |
| Q3 2020 | $665,000 | -6.6% | 8,267 | 0.0% | 0.14% | -13.4% |
| Q2 2020 | $712,000 | +6.1% | 8,267 | 0.0% | 0.16% | +4.0% |
| Q1 2020 | $671,000 | -2.9% | 8,267 | 0.0% | 0.15% | +33.6% |
| Q4 2019 | $691,000 | -4.4% | 8,267 | 0.0% | 0.11% | -19.9% |
| Q3 2019 | $723,000 | +6.8% | 8,267 | 0.0% | 0.14% | +5.2% |
| Q2 2019 | $677,000 | +0.7% | 8,267 | 0.0% | 0.13% | +152.8% |
| Q1 2019 | $672,000 | +26.3% | 8,267 | +2.3% | 0.05% | -43.0% |
| Q4 2018 | $532,000 | -14.6% | 8,082 | 0.0% | 0.09% | -13.9% |
| Q3 2018 | $623,000 | +4.4% | 8,082 | 0.0% | 0.11% | -4.4% |
| Q2 2018 | $597,000 | +15.0% | 8,082 | +1.3% | 0.11% | +20.2% |
| Q1 2018 | $519,000 | +0.6% | 7,975 | 0.0% | 0.09% | 0.0% |
| Q4 2017 | $516,000 | +1.8% | 7,975 | -1.2% | 0.09% | -1.1% |
| Q3 2017 | $507,000 | +3.7% | 8,075 | 0.0% | 0.10% | +23.4% |
| Q2 2017 | $489,000 | +32.2% | 8,075 | +13.3% | 0.08% | +6.9% |
| Q1 2017 | $370,000 | +25.4% | 7,125 | +7.3% | 0.07% | +176.9% |
| Q4 2016 | $295,000 | -10.3% | 6,643 | -3.9% | 0.03% | -53.6% |
| Q3 2016 | $329,000 | +5.1% | 6,913 | 0.0% | 0.06% | -18.8% |
| Q2 2016 | $313,000 | +9.4% | 6,913 | -0.9% | 0.07% | +3.0% |
| Q1 2016 | $286,000 | +15.8% | 6,973 | +7.7% | 0.07% | +19.6% |
| Q4 2015 | $247,000 | +17.6% | 6,473 | +1.3% | 0.06% | +16.7% |
| Q3 2015 | $210,000 | -59.4% | 6,393 | -13.5% | 0.05% | -52.0% |
| Q2 2015 | $517,000 | +5.7% | 7,393 | +3.5% | 0.10% | +9.9% |
| Q1 2015 | $489,000 | +6.8% | 7,143 | +14.4% | 0.09% | +35.8% |
| Q4 2014 | $458,000 | -48.9% | 6,243 | -50.0% | 0.07% | -11.8% |
| Q3 2014 | $896,000 | -0.7% | 12,486 | 0.0% | 0.08% | +7.0% |
| Q2 2014 | $902,000 | -6.2% | 12,486 | -4.6% | 0.07% | -9.0% |
| Q1 2014 | $962,000 | +9.8% | 13,086 | +4.0% | 0.08% | +14.7% |
| Q4 2013 | $876,000 | +28.1% | 12,586 | +21.0% | 0.07% | +25.9% |
| Q3 2013 | $684,000 | +10.7% | 10,398 | +16.6% | 0.05% | +1.9% |
| Q2 2013 | $618,000 | +90.7% | 8,914 | +100.0% | 0.05% | -5.4% |
| Q1 2013 | $324,000 | – | 4,457 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |